Key facts
- Review Piper’s last known valuation is $330K (Mar 2023).
- It has raised $20K; the latest was Seed Round in Jan 2025.
- Notable investors include Techstars.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Review Piper
- ·The full record, as it builds
Funding rounds
No funding rounds for Review Piper are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Review Piper
Developer of healthcare practice management software designed to simplify revenue cycle management and compliance. The company's software centralizes billing records, compliance files, and attestation reports into one location by providing tools for denial prevention, proactive compliance, revenue optimization analytics, and audit-ready documentation, enabling healthcare companies to streamline workflows, improve billing and compliance performance, reduce denial rates, ensure audit readiness, and optimize revenue collection.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2022
- Website
- reviewpiper.com/
- Ownership
- Privately Held (backing)
Review Piper doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Review Piper shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Review Piper in its N-PORT filings yet. We sweep new filings monthly.